BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO AND Prognosis
7 results:

  • 1. "Time" for obesity-related cancer: The role of the circadian rhythm in cancer pathogenesis and treatment.
    Miro C; Docimo A; Barrea L; Verde L; Cernea S; Sojat AS; Marina LV; Docimo G; Colao A; Dentice M; Muscogiuri G
    Semin Cancer Biol; 2023 Jun; 91():99-109. PubMed ID: 36893964
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. An organoid-based drug screening identified a menin-MLL inhibitor for endometrial cancer through regulating the HIF pathway.
    Chen J; Zhao L; Peng H; Dai S; Quan Y; Wang M; Wang J; Bi Z; Zheng Y; Zhou S; Liu Y; Chen C; Na F
    Cancer Gene Ther; 2021 Feb; 28(1-2):112-125. PubMed ID: 32632269
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. arnt-dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer.
    Chen G; Cai ZD; Lin ZY; Wang C; Liang YX; Han ZD; He HC; Mo RJ; Lu JM; Pan B; Wu CL; Wang F; Zhong WD
    Mol Carcinog; 2020 Aug; 59(8):897-907. PubMed ID: 32319143
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. All-Cause Mortality for Life Insurance Applicants with a History of prostate cancer.
    Freitas SA; MacKenzie R; Wylde DN; Roudebush BT; Bergstrom RL; Holowaty JC; Beckman M; Rigatti SJ; Gill S
    J Insur Med; 2017; 47(2):95-106. PubMed ID: 29490159
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genome-wide copy number analysis reveals candidate gene loci that confer susceptibility to high-grade prostate cancer.
    Poniah P; Mohd Zain S; Abdul Razack AH; Kuppusamy S; Karuppayah S; Sian Eng H; Mohamed Z
    Urol Oncol; 2017 Sep; 35(9):545.e1-545.e11. PubMed ID: 28527622
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. HIF1alpha isoforms in benign and malignant prostate tissue and their correlation to neuroendocrine differentiation.
    Monsef N; Soller M; Panagopoulos I; Abrahamsson PA
    BMC Cancer; 2010 Jul; 10():385. PubMed ID: 20663134
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Study of incidental carcinoma of the prostate. Part 1. Pathological analysis related to the clinical features].
    Fujita T; Kanimoto Y; Akino H; Okada K; Shiraishi T; Nakakuki K
    Hinyokika Kiyo; 1991 Jul; 37(7):695-703. PubMed ID: 1927769
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.